Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RAMON SANTIAGO

Allopathic & Osteopathic Physicians Family Medicine

NPI
1013923713
CMS profile
318796
Location
TAMPA, FL

General Payments · PY2018–2024

$9,772.83

  • Reported across 553 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$711.67

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $711.67 34

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,513.84 88
PY2019 $1,749.53 99
PY2020 $1,427.93 86
PY2021 $1,930.22 112
PY2022 $1,390.31 80
PY2023 $1,049.33 54
PY2024 $711.67 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $18.98 02/27/2024 Food and Beverage Undisputed 01/23/2026 1139315556 CMS
AstraZeneca Pharmaceuticals LP $81.00 01/31/2024 Food and Beverage Undisputed 01/23/2026 1105760015 CMS
AstraZeneca Pharmaceuticals LP $14.12 02/07/2024 Food and Beverage Undisputed 01/23/2026 1104494892 CMS
AstraZeneca Pharmaceuticals LP $13.44 03/05/2024 Food and Beverage Undisputed 01/23/2026 1104586836 CMS
AstraZeneca Pharmaceuticals LP $18.36 03/06/2024 Food and Beverage Undisputed 01/23/2026 1105458729 CMS
AstraZeneca Pharmaceuticals LP $13.19 03/15/2024 Food and Beverage Undisputed 01/23/2026 1105338581 CMS
AstraZeneca Pharmaceuticals LP $13.32 04/16/2024 Food and Beverage Undisputed 01/23/2026 1105558518 CMS
AstraZeneca Pharmaceuticals LP $16.65 04/18/2024 Food and Beverage Undisputed 01/23/2026 1104347262 CMS
AstraZeneca Pharmaceuticals LP $13.44 05/02/2024 Food and Beverage Undisputed 01/23/2026 1105769746 CMS
AstraZeneca Pharmaceuticals LP $21.15 05/16/2024 Food and Beverage Undisputed 01/23/2026 1105597433 CMS
AstraZeneca Pharmaceuticals LP $15.77 06/12/2024 Food and Beverage Undisputed 01/23/2026 1104639129 CMS
AstraZeneca Pharmaceuticals LP $16.55 10/31/2024 Food and Beverage Undisputed 01/23/2026 1104697824 CMS
AstraZeneca Pharmaceuticals LP $13.60 12/19/2024 Food and Beverage Undisputed 01/23/2026 1105689722 CMS
Bayer Healthcare Pharmaceuticals Inc. $27.09 03/13/2024 Food and Beverage Undisputed 01/23/2026 1086259634 CMS
Bayer Healthcare Pharmaceuticals Inc. $28.89 09/06/2024 Food and Beverage Undisputed 01/23/2026 1086200262 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.84 07/25/2024 Food and Beverage Undisputed 01/23/2026 1117838486 CMS
Esperion Therapeutics, Inc. $15.00 04/04/2024 Food and Beverage Undisputed 01/23/2026 1129453806 CMS
GlaxoSmithKline, LLC. $23.88 02/22/2024 Food and Beverage Undisputed 01/23/2026 1116695637 CMS
GlaxoSmithKline, LLC. $22.18 04/02/2024 Food and Beverage Undisputed 01/23/2026 1115979409 CMS
GlaxoSmithKline, LLC. $21.96 05/30/2024 Food and Beverage Undisputed 01/23/2026 1116676779 CMS
GlaxoSmithKline, LLC. $17.39 08/26/2024 Food and Beverage Undisputed 01/23/2026 1116362733 CMS
GlaxoSmithKline, LLC. $19.36 10/16/2024 Food and Beverage Undisputed 01/23/2026 1116559213 CMS
Kowa Pharmaceuticals America, Inc. $14.74 11/25/2024 Food and Beverage Undisputed 01/23/2026 1113470223 CMS
Lilly USA, LLC $20.90 02/29/2024 Food and Beverage Undisputed 01/23/2026 1135368956 CMS
Lilly USA, LLC $19.65 03/22/2024 Food and Beverage Undisputed 01/23/2026 1135368958 CMS
Novo Nordisk Inc $14.43 04/02/2024 Food and Beverage Undisputed 01/23/2026 1096891133 CMS
Novo Nordisk Inc $17.69 04/26/2024 Food and Beverage Undisputed 01/23/2026 1097332879 CMS
Novo Nordisk Inc $22.40 11/06/2024 Food and Beverage Undisputed 01/23/2026 1097200523 CMS
Phathom Pharmaceuticals, Inc. $27.48 04/08/2024 Food and Beverage Undisputed 01/23/2026 1151120502 CMS
Phathom Pharmaceuticals, Inc. $24.53 07/18/2024 Food and Beverage Undisputed 01/23/2026 1151120504 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.17 03/19/2024 Food and Beverage Undisputed 01/23/2026 1153446021 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.86 04/25/2024 Food and Beverage Undisputed 01/23/2026 1153606866 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.77 05/20/2024 Food and Beverage Undisputed 01/23/2026 1153433645 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.89 06/26/2024 Food and Beverage Undisputed 01/23/2026 1153599657 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.